Results: Our findings demonstrated statistically significant differences in NIH-CPSI scores between the patients and control groups (P
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Background/aim: To develop the first Turkish version of the National Institutes of Health Chronic Prostatitis Symptom Index (NIHCPSI) questionnaire and to investigate its validity and reliability in men with chronic prostatitis/chronic pelvic pain syndrome (CP/ CPPS) and healthy controls.Material and methods: A total of 204 patients, 116 CP/CPPS and a control group which consisted of 88 healthy individuals were included in this prospective study.
📊
Key Findings & Data:Using the Turkish version of the NIH CPSI, 40 patients completed the same questionnaires twice at 2-week intervals for test-retest concordance.
💡
Conclusion & Impact:Results: Our findings demonstrated statistically significant differences in NIH-CPSI scores between the patients and control groups (P
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Background/aim: To develop the first Turkish version of the National Institutes of Health Chronic Prostatitis Symptom Index (NIHCPSI) questionnaire and to investigate its validity and reliability in men with chronic prostatitis/chronic pelvic pain syndrome (CP/ CPPS) and healthy controls.Material and methods: A total of 204 patients, 116 CP/CPPS and a control group which consisted of 88 healthy individuals were included in this prospective study. The NIH-CPSI form was first translated into Turkish and later on back into English. Using the Turkish version of the NIH CPSI, 40 patients completed the same questionnaires twice at 2-week intervals for test-retest concordance. To evaluate internal consistency and test-retest reliability, Cronbach’s alpha value, and the Spearman correlation test were utilized respectively. Results: Our findings demonstrated statistically significant differences in NIH-CPSI scores between the patients and control groups (P
🔖
Cite This Article
NARTE, K. F., TARHAN, F., COŞKUN, A., CAN, U., KAVUKOĞLU, Ö. (2022). Reliability and validity of the National Institutes of Health Chronic Prostatitis Symptom Index questionnaire in the Turkish Population. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 2, 501–507. https://ajindex.com/articles/609958
Litwin MS, McNaughton-Collins M, Fowler FJ Jr, Nickel JC, Calhoun EA et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. The Journal of Urology 1999
162 (2 ): 369- 375. doi: 10.1016/s0022-5347(05)68562-x 2. Magnus F, Baranowski AP, Elneil S, Engeler D, Hughes J et al. EAU Guidelines on Chronic Pelvic Pain. Europan Urology 2010
57 (1): 35-48. doi: 10.1016/j.eururo.2009.08.020 3. Moon TD, L Hagen, and DM Heisey. Urinary symptomatology in younger men. Urology 1997
50 (5): 700-703. doi: 10.1016/ S0090-4295(97)00336-1 4. Schaeffer AJ. Epidemiology and demographics of prostatitis. Andrologia 2003
35 (5): 252-257. doi: 10.1046/j.1439- 0272.2003.00584.x 5. Nickel JC, Downey J, Hunter D, Clark J. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. The Journal of Urology 2001
165 (3): 842-845. doi: 10.1016/s0022-5347(05)66541-x 6. Nickel JC, Nyberg LM, Hennenfent M. Research guidelines for chronic prostatitis: consensus report from the first National Institutes of Health International Prostatitis Collaborative Network. Urology 1999
54 (2): 229-233. doi: 10.1016/s0090- 4295(99)00205-8 7. Trinchieri A, Magri V, Cariani L, Bonamore R, Restelli A et al. Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Archivio Italiano di Urologia, Andrologia 2007
79 (2): 67-70. 8. Shoskes DA, Nickel JC, Rackley RR, Pontari MA. Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer and Prostatic Diseases 2009
12 (2): 177-183. doi: 10.1038/ pcan.2008.42 9. Magri V, Wagenlehner F, Perletti G, Schneider S, Marras E et al. Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. The Journal of Urology 2010
184 (6): 2339-2345. doi: 10.1016/j.juro.2010.08.025 10. Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Lieber MM et al. Low agreement between previous physician diagnosed prostatitis and national institutes of health chronic prostatitis symptom index pain measures. The Journal of Urology 2004